**BREAKING: MATTHEW PERRY’S ‘ACCIDENTAL’ DROWNING — DOCTORS SILENT, PHARMA STOCKS SURGE**
In the wake of Matthew Perry’s tragic death, the official narrative says ‘ketamine therapy gone wrong’ — but sources close to the investigation are asking: *Who really benefits?*
Court documents show Perry had been receiving ‘off-label’ ketamine infusions from a celebrity doctor who just last month secured a multi-million dollar contract with a major pharma chain. Insiders say the doctor was allegedly ‘encouraging high-dose sessions’ — despite known risks.
Meanwhile, as Perry’s family mourns, shares of the company behind the patented ketamine spray formulation rose 12% in two days. The same week, a new FDA fast-track was announced for a ‘breakthrough’ depression treatment using… you guessed it, ketamine.
A former DEA agent, speaking anonymously, said, *“This isn’t an accident. This is a warning sign. When a high-profile death conveniently shifts public fear into demand for a controlled substance, follow the money.”*
Perry’s official toxicology report remains sealed. His family has not spoken publicly on the ‘therapy’ details.
🔍 **Follow the trail. Ask: Who profits from a dead addict?**